...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients
【24h】

Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients

机译:医院内微生物血流感染对危重患者结局的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aims of this study were to compare the clinical and microbiological characteristics from patients with polymicrobial bloodstream infections (BSI) to those from patients with monomicrobial BSI and to determine their influence on the prognosis. A prospective study was conducted on 371 nosocomial BSI in an intensive care unit (ICU). Seventyfive (20.2%) of them were polymicrobial. The mean APACHE II score at the onset of bacteremia in polymicrobial and monomicrobial BSI were 17.7±6.6 and 18.9±7.5, respectively (p=0.228). Severe sepsis and septic shock were present in 68.0% and 50.6% of polymicrobial BSI and in 73.9% and 55.1% of monomicrobial BSI, respectively (p=0.298 and p=0.494, respectively). The length of stay and the length of stay post-infection were significantly longer in patients with polymicrobial BSI. APACHE II score at the onset of BSI, high-risk microorganisms, and septic shock were predictors of related mortality, but polymicrobial BSI and inadequate empirical antimicrobial treatment were not. Our findings suggest that the clinical and microbiological characteristics of polymicrobial BSI are not different from monomicrobial BSI, and polymicrobial BSI do not have any influence on the related mortality. However, they occurred in patients with a longer length of stay in the hospital and were associated with longer stays in the hospital after the episode of BSI.
机译:本研究的目的是比较多微生物血流感染(BSI)患者与单微生物BSI患者的临床和微生物学特征,并确定其对预后的影响。在重症监护病房(ICU)中对371例医院BSI进行了前瞻性研究。其中七十五(20.2%)为多菌种。微生物菌群和单菌菌群BSI在菌血症发生时的平均APACHE II评分分别为17.7±6.6和18.9±7.5(p = 0.228)。严重脓毒症和败血性休克分别占68.0%和50.6%的微生物BSI和73.9%和55.1%的单微生物BSI(分别为p = 0.298和p = 0.494)。多微生物BSI患者的住院时间和感染后的住院时间明显更长。 BSI发生时的APACHE II评分,高危微生物和败血性休克是相关死亡率的预测因素,而BSI微生物和经验性抗生素治疗不足则不是。我们的研究结果表明,微生物BSI的临床和微生物学特征与单微生物BSI并无不同,并且微生物BSI对相关死亡率没有任何影响。但是,它们发生在住院时间较长的患者中,并且与BSI发作后住院时间较长有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号